Latest Glucocorticoids Stories
WALTHAM, Mass., April 26 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, despite increased competition from several emerging agents, GlaxoSmithKline's Advair will remain surveyed pulmonologists' and primary care physicians' (PCPs) favored fixed-dose long-acting beta2 agonist (LABA)/inhaled corticosteroid (ICS) combination inhaler through 2013 for the treatment of asthma and chronic obstructive...
Patients hospitalized with mild to moderate community-acquired pneumonia (CAP) should not be routinely prescribed prednisolone, a corticosteroid, as it is associated with a recurrence of symptoms after its withdrawal, according to the first randomized double-blind clinical trial to address the subject.
WALTHAM, Mass., Feb.
PARSIPPANY, N.J., Jan. 19 /PRNewswire-USNewswire/ -- Denmark-based LEO Pharma, a global leader in dermatology and critical care, today announced its official launch in the U.S. Headquartered in Parsippany, New Jersey, LEO Pharma U.S.
Recent studies show that one in three Canadians suffer from stress and the number is on the rise, but stress isn't a new problem.
NEW YORK, Nov.
A recent study determined glucocorticoid-induced osteoporosis (OP) is now treatable with Teriparatide, a synthetic form of the human parathyroid hormone.
Scientists have long struggled to understand the body's biological clock. Its tick-tock wakes us up, reminds us to eat and tells us when to go to bed. But what sets that circadian rhythm?
BASEL and REINACH, Switzerland, September 2 /PRNewswire/ -- - CAPRA-2-Data Will be Used to File for US Marketing Approval Nitec Pharma AG ("Nitec" or "Nitec Pharma"), a Switzerland-based specialty pharma company focused on the development and commercialization of medicines to treat chronic inflammation and pain-related diseases, today announced positive results from the second pivotal phase III trial for its lead product, Lodotra(TM). The CAPRA-2 study (Circadian Administration...
Children whose families are poor early in their lives have an increased risk of chronic disease later in life, Canadian researchers said. University of British Columbia researchers Gregory Miller and Michael Kobor performed genome-wide profiling in 103 healthy adults age 25-40, who were either experienced low or high early-life socioeconomic circumstances related to income, education and occupation during the first five years of life. The two groups were similar in socioeconomic status at the...
- The parings of haberdine; also, any kind of fragments.